Press release
Deadline on February 28th coming up in Lawsuit for Investors in shares of Instadose Pharma Corp. (OTC: INSD)
A Deadline is coming up on February 28, 2022 in the lawsuit for certain investors in Instadose Pharma Corp. (OTC: INSD).
Investors who purchased shares of Instadose Pharma Corp. (OTC: INSD) have certain options and there are strict and short deadlines running. Deadline: February 28, 2022. OTC: INSD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of Virgina the plaintiff alleges on behalf of purchasers of Instadose Pharma Corp. (OTC: INSD) common shares between December 8, 2020 and November 24, 2021, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between December 8, 2020 and November 24, 2021, the Defendants made false and/or misleading statements and/or failed to disclose that Instadose had performed inadequate due diligence into the Business Combination and/or ignored significant red flags associated with Instadose Canada, that Instadose's internal controls and policies were inadequate to detect and/or prevent impermissible trading activity by control persons of the Company, that the foregoing subjected Instadose to a heightened risk of regulatory scrutiny and enforcement action, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Instadose Pharma Corp. (OTC: INSD) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on February 28th coming up in Lawsuit for Investors in shares of Instadose Pharma Corp. (OTC: INSD) here
News-ID: 2559169 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Instadose
Investigation announced for Long-Term Investors in Instadose Pharma Corp. (OTC: …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Instadose Pharma Corp. f/k/a Mikrocoze, Inc.
Investors who are current long term investors in Instadose Pharma Corp. (OTC: INSD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in OTC: INSD stocks follows a lawsuit…
Lawsuit filed for Investors in shares of Instadose Pharma Corp. (OTC: INSD) file …
An investor, who purchased shares of Instadose Pharma Corp. (OTC: INSD), filed a lawsuit alleged violations of Federal Securities Laws by Instadose Pharma Corp. f/k/a Mikrocoze, Inc.
Investors who purchased shares of Instadose Pharma Corp. (OTC: INSD) have certain options and for certain investors are short and strict deadlines running. Deadline: February 28, 2022. OTC: INSD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Chesapeake, VA…
Investigation announced for Investors in Instadose Pharma Corp. (OTC: INSD)
An investigation was announced over potential securities laws violations by Instadose Pharma Corp. and certain of its directors and officers in connection with certain financial statements.
Investors who purchased shares of Instadose Pharma Corp. (OTC: INSD), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Instadose…
Radiation Detection, Monitoring And Safety Market Growth, Trends, And Forecast 2 …
The increased use of radioactive materials in areas, such as power production, industrial processing, medical research, processing, and the security sector, coupled with the increased threat of terrorism, has intensified the need for equipment offering protection against radioactive radiations. In addition, the amplified stability of manufacturing industries is likely to augment the growth of the market during the forecast period. The usage of radiography testing in the manufacturing industry to…
Dosimeters Market Estimated Growth By Leading Players Thermo Fisher Scientific I …
Global Dosimeters Market, by Product Type (Active Dosimeters and Passive Dosimeters), by Modality (Portable Dosimeters (Wearable (Collar Level, Chest Level, Waist Level, Wrist Level, and Finger Level (i.e. Ring Dosimeters)), and Non-wearable), and Bench-top Dosimeters), by End User (Hospitals, Ambulatory Care Centers, Research Institutes, and Healthcare Companies), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 847.0 Mn in 2017,…
Dosimeters Market to Surpass US$ 1,220.1 Mn Threshold by 2026
Global Dosimeters Market, by Product Type (Active Dosimeters and Passive Dosimeters), by Modality (Portable Dosimeters (Wearable (Collar Level, Chest Level, Waist Level, Wrist Level, and Finger Level (i.e. Ring Dosimeters)), and Non-wearable), and Bench-top Dosimeters), by End User (Hospitals, Ambulatory Care Centers, Research Institutes, and Healthcare Companies), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 847.0 Mn in 2017,…
